Phase 2 study of the GI-4000 KRAS vaccine following curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, G12V or G12R mutation Meeting Abstract
| Authors: | Chaft, J. E.; Arcila, M.; Patel, P.; Apelian, D. M.; Mattson, A.; Coeshott, C.; Kris, M. G.; Azzoli, C. G. |
| Abstract Title: | Phase 2 study of the GI-4000 KRAS vaccine following curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, G12V or G12R mutation |
| Meeting Title: | 15th World Conference on Lung Cancer (IASLC) |
| Keywords: | vaccine; early stage; kras-mutant nsclc |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 8 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Oct 27-31 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-11-01 |
| Start Page: | S302 |
| Language: | English |
| ACCESSION: | WOS:000339624901148 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.JTO.0000438438.14562.c8 |
| Notes: | Meeting Abstract: MO08.04 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work